In vivo induction of cytochrome p450 CYP3A expression in rat leukocytes using various inducers

被引:22
作者
Mahnke, A
Roos, PH
Hanstein, WG
Chabot, GG
机构
[1] INST GUSTAVE ROUSSY,CNRS URA 147,PHARMACOTOXICOL & PHARMACOGENET LAB,F-94805 VILLEJUIF,FRANCE
[2] RUHR UNIV BOCHUM,INST PHYSIOL CHEM,D-44780 BOCHUM,GERMANY
关键词
cytochromes P450; CYP3A; induction; leukocyte; noninvasive test; Western blot;
D O I
10.1016/0006-2952(96)00095-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although the induction of cytochromes P450 3A (CYP3A) is relatively well characterized in liver, its inducibility in an easily available tissue such as the peripheral leukocytes is not known. The purpose of this study was, therefore, to determine if CYP3A is inducible in vivo in peripheral leukocytes. Microsomes from rat leukocytes and liver were examined for CYP3A protein expression using Western blotting with a rabbit polyclonal antibody against rat CYP3A. Although CYP3A was not detected in control leukocytes, in vivo treatment with known CYP3A inducers (dexamethasone, clotrimazole, phenobarbital, pregnenolone-16 alpha-carbonitrile) resulted in CYP3A leukocyte levels of 0.2-0.8 pmol/mg protein. This leukocyte induction was approximately 1000-fold lower than in induced liver. Interestingly, there was an apparent linear relationship between leukocyte and liver CYP3A contents (r(2) = 0.748, n = 29). These results not only demonstrate for the first time that CYP3A is inducible in rat leukocytes after in vivo treatment with various CYP3A inducers, but also suggest that peripheral leukocytes could be used to assess induction in vivo.
引用
收藏
页码:1579 / 1582
页数:4
相关论文
共 30 条
[11]   IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES [J].
KOLARS, JC ;
SCHMIEDLINREN, P ;
SCHUETZ, JD ;
FANG, C ;
WATKINS, PB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1871-1878
[12]   A MAJOR GLUCOCORTICOID-INDUCIBLE P450 IN RAT-LIVER IS NOT P450 3A1 [J].
KOMORI, M ;
ODA, Y .
JOURNAL OF BIOCHEMISTRY, 1994, 116 (01) :114-120
[13]   EXTRAHEPATIC METABOLISM OF DRUGS IN HUMANS [J].
KRISHNA, DR ;
KLOTZ, U .
CLINICAL PHARMACOKINETICS, 1994, 26 (02) :144-160
[14]  
LAEMMLI UK, 1970, NATURE, V227, P2804
[15]   PARTICIPATION OF P450-3A ENZYMES IN RAT HEPATIC-MICROSOMAL RETINOIC ACID 4-HYDROXYLATION [J].
MARTINI, R ;
MURRAY, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (01) :57-66
[16]   THE IMMUNOCYTOCHEMICAL LOCALIZATION AND DISTRIBUTION OF CYTOCHROME-P-450 IN NORMAL HUMAN HEPATIC AND EXTRAHEPATIC TISSUES WITH A MONOCLONAL-ANTIBODY TO HUMAN CYTOCHROME-P-450 [J].
MURRAY, GI ;
BARNES, TS ;
SEWELL, HF ;
EWEN, SWB ;
MELVIN, WT ;
BURKE, MD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (04) :465-475
[17]   THE P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS, EARLY TRIVIAL NAMES OF ENZYMES, AND NOMENCLATURE [J].
NELSON, DR ;
KAMATAKI, T ;
WAXMAN, DJ ;
GUENGERICH, FP ;
ESTABROOK, RW ;
FEYEREISEN, R ;
GONZALEZ, FJ ;
COON, MJ ;
GUNSALUS, IC ;
GOTOH, O ;
OKUDA, K ;
NEBERT, DW .
DNA AND CELL BIOLOGY, 1993, 12 (01) :1-51
[18]  
OMIECINSKI CJ, 1990, CANCER RES, V50, P4315
[19]   EFFECT OF AGING AND OTHER FACTORS ON MONOCYTE ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY [J].
PUTNAM, AD ;
PETERSON, TC .
MECHANISMS OF AGEING AND DEVELOPMENT, 1991, 60 (01) :61-74
[20]   FORMATION OF LIGAND AND METABOLITE COMPLEXES AS A MEANS FOR SELECTIVE QUANTITATION OF CYTOCHROME-P450 ISOZYMES [J].
ROOS, PH ;
GOLUBCIOSK, B ;
KALLWEIT, P ;
KAUCZINSKI, D ;
HANSTEIN, WG .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (11) :2239-2250